Dr. Jason Saylor, DO
Board-certified in family medicine, Chief Medical Officer
Video visits across Florida · in person in Tampa (Carrollwood)
Wesley Chapel residents · Florida telehealth (video)
GLP-1 weight loss by secure video for Wesley Chapel residents, with Dr. Jason Saylor, DO. No drive and no waiting room.

You’ll see Dr. Jason Saylor, DO.
Prefer a call first?
Request a visit
Tell us how to reach you and, if you like, what is going on. We confirm your coverage before your first visit.
The clinician who will see you.
Board-certified in family medicine, Chief Medical Officer
Video visits across Florida · in person in Tampa (Carrollwood)
Booking opens the clinician’s Zocdoc calendar in a new tab, set to new-patient video visits. Prefer to talk to someone first? Use the form and a care coordinator will call you.
Four steps from booking to a plan you can follow, without leaving Wesley Chapel.
Pick a time on Zocdoc, or send the form and a care coordinator calls you back, usually within one business day.
Before the visit you receive a secure video link. Join from a phone, tablet or laptop, from a private spot in Florida.
Dr. Jason Saylor, DO, reviews your history by video and orders labs at a Quest or LabCorp near you before deciding whether a GLP-1 fits.
If you start a medication, video follow-ups track side effects and adjust the dose step by step.
Most Wesley Chapel patients choose video. If you would rather sit in the room, our Tampa office is about 25 minutes away.
Recommended for Wesley Chapel
Serving Wesley Chapel, Pasco County

Prefer in person?
About 25 min from Wesley Chapel by car via I-275 S, outside rush hour
If you live in Wesley Chapel you may already know Ascend Mind and Body's psychiatry office on Cashford Circle. GLP-1 weight loss is not offered in person there. Dr. Jason Saylor, DO runs the program by secure video, and his exam room is at the Tampa (Carrollwood) office, about 25 minutes south outside rush hour and roughly 19 miles by I-275 S, which splits from I-75 at Exit 274.
Who qualifies. Under their labeling these medicines are generally for adults at a BMI of 30 or more, or 27 or more alongside a weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol or sleep apnea. Not a fit if you have:
Labs without leaving the area. Quest's directory shows a site on State Road 54 and another on Foggy Creek Road, and Labcorp lists one on Bruce B. Downs Blvd. The Census geocoder places all of them inside the Wesley Chapel census area, so residents of Seven Oaks, Wiregrass Ranch or Meadow Pointe can fold the baseline panel into an ordinary errand run.
How the visits fit a Pasco week. The dose rises in steps of at least four weeks, a video check-in comes before each one, and a hard step can be held. On video, a check-in takes the length of the call rather than a round trip down I-275. Our GLP-1 side effects guide explains what is expected after a step and what is a warning sign.
Emergency care close by. Two hospitals on Bruce B. Downs Blvd run 24-hour emergency departments: AdventHealth Wesley Chapel and BayCare Hospital Wesley Chapel. They are where to go for severe abdominal pain, vomiting that will not settle or signs of dehydration, and 911 is the call for anything that feels life-threatening.
Start with a video visit with Dr. Saylor. If you would rather make the first appointment in Carrollwood, say so when you book.
We work with many major commercial plans and offer self-pay options. Coverage varies by plan and service. Our team will confirm with you.
Insurance questions go to our care team, who confirm your coverage with you before your first visit.
Call (813) 670-3331 or read how insurance works here.
The longer answers, one topic at a time.
Wesley Chapel is full of storefronts that will send a GLP-1 prescription off a five-minute questionnaire with no exam and no labs. That model misses the contraindications a proper workup catches. Here, a physician reads your labs first.
Request a callbackA physician-led program orders labs before prescribing, screens for contraindications by exam and history rather than a questionnaire, and keeps the same prescriber managing your case from intake through maintenance. Many local weight-loss storefronts are staffed by aestheticians or medical assistants operating under a remote physician who never actually sees the patient.
Dr. Jason Saylor, DO is a family medicine physician and Chief Medical Officer at Ascend, and he is the prescriber for this program. Weight management sits inside the same practice that manages your blood pressure, your thyroid, and your diabetes risk, which matters because GLP-1 medications interact with all three. If your labs show something unrelated to weight, like an elevated liver enzyme or an abnormal thyroid panel, it gets addressed in the same visit instead of falling through the cracks between a weight-loss clinic and a separate primary care doctor you may not have.
That model can work for some people, but a med-spa or subscription counter also means nobody is examining you, nobody is reading your labs in context, and if something goes wrong there is no continuity of care. We are not the cheapest option in Pasco County, and we will not pretend to be. What you get instead is a licensed physician reading your labs, a documented follow-up schedule, and a practice that can treat what your workup finds, whether that turns out to be prediabetes, high cholesterol, or high blood pressure, without referring you somewhere else first.
Fragmentation is the silent tax on modern weight loss care. The injection comes from a med-spa portal, the blood pressure medication from a primary care office, the sleep study from a third system, and nobody's software talks to anybody's, so nobody is accountable for the whole patient. At Ascend the model inverts. Your GLP-1 evaluation, your labs, your chronic disease management, and your follow-ups all live in a single record under a single medical team.
That structure isn't cosmetic. When your titration visit shows climbing blood pressure, the same practice adjusts the plan. When labs drawn for weight loss eligibility turn up an HbA1c in diabetic range, the diagnosis and its management don't require a referral to somewhere across town. When low testosterone is part of the picture for a man whose weight won't move, our TRT program runs within the same practice, on the same chart. Coordination stops being a phone-tag project and becomes the default state of your care.
The same logic extends to the mental health side of weight. Screening for mood disorders and eating disorders is a required part of a responsible GLP-1 evaluation, and when that screen finds something, many weight loss programs have to refer you elsewhere. Ascend also provides psychiatry and talk therapy, so a finding becomes a warm handoff inside the same practice, on the same chart, instead of a referral letter that goes nowhere. Weight, sleep, mood, and metabolic health tangle together in real patients; a practice built around all of them is the point.
The phrase gets used loosely in weight-loss marketing. At minimum, medically supervised weight loss should include:
If a program cannot describe its follow-up cadence to you before you start, that is worth asking about directly. A supervised program should be able to tell you when it will see you next and what it is watching for.
We will not prescribe a GLP-1 over a form with no exam and no labs. We will not quote you a promised number of pounds. We will not push a compounded product that is not clinically indicated for you. And we will not manage a Florida-licensed prescription for someone physically located in another state.
The labeling for chronic weight management covers adults 18 and older with a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as hypertension, high cholesterol, type 2 diabetes, or obstructive sleep apnea. Meeting the BMI threshold does not automatically mean medication is the right next step. We confirm eligibility through history, exam, and labs, not a BMI calculator alone.
We screen carefully for contraindications before prescribing any GLP-1 medication: a personal or family history of medullary thyroid carcinoma, MEN2 syndrome, severe gastroparesis, a prior episode of pancreatitis, an active eating disorder, pregnancy or plans to become pregnant, and severe gallbladder disease. None of these are automatic disqualifiers from all care, but they change which options are safe to consider. We also screen for the conditions weight often masks or worsens, including high cholesterol, sleep apnea, mood disorders, and fatty liver disease, so those get addressed alongside weight rather than ignored.
This program is for adults 18 and older only. Weight concerns in patients under 18 are handled through a different specialist, and we are glad to help point families in the right direction.
GLP-1 driven weight loss reduces lean muscle as well as fat, not just fat alone. That is a real consideration, especially for older adults. It is one reason our program pairs medication with protein-forward nutrition and resistance-training basics from the start, so the weight you lose is weighted toward fat and you protect the muscle that keeps your metabolism and mobility intact. A clinic that hands you an injection and nothing else is ignoring half the picture.
Illustrative
Medical weight loss for Wesley Chapel patients starts with labs and a physician visit, then follows your response and side effects through structured dose titration.
GLP-1 receptor agonists work by slowing how fast your stomach empties and by reducing appetite signaling in the brain, so you feel full sooner and stay full longer. Tirzepatide adds a second receptor (GIP) to that mechanism. They are prescription medications, not supplements, and they require a physician evaluation, lab monitoring, and honest disclosure of side effects and contraindications before starting.
What we prescribe depends on your workup, your insurance, your other health conditions, and how you tolerate the medication once you start. Every option below is discussed in plain terms, including how it works and what the trial data actually showed. Before a first dose, it helps to read about GLP-1 injection sites and rotation.
The newest medication is not automatically the right one. Tolerance, coverage, and your other conditions all factor in.
Tirzepatide tends to produce more average weight loss in trials, but semaglutide has a longer real-world track record for weight management specifically, and some patients simply tolerate one better than the other. We decide together after your labs and history are in, not before, and coverage often makes the practical difference.
| Factor | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GIP/GLP-1 receptor agonist |
| Average trial weight loss | About 14.9% at 68 weeks (STEP-1) | About 20 to 22% at 72 weeks (SURMOUNT-1) |
| Dosing | Weekly injection, gradual titration | Weekly injection, gradual titration |
| Common side effects | Nausea and constipation more common | Diarrhea more common, often less nausea |
Trial results describe group averages under study conditions and do not predict your individual result. We confirm coverage and current availability when you call.
Ascend prescribes commercially manufactured brand medications through licensed pharmacies. We do not run a compounding-pharmacy subscription model. If you have been offered a cheaper semaglutide or tirzepatide elsewhere in Wesley Chapel, ask what you would actually be getting before you start. Compounded versions are not manufactured under the same quality controls, and dosing errors and adverse events have been reported with some compounded GLP-1 products during periods of brand-name shortage. Our team will go over your coverage options with you, including any manufacturer assistance program, rather than defaulting to a compounded product.
We would rather you hear the risks from us before you start than discover them from the pharmacy insert alone.
The most common side effects of GLP-1 medications are gastrointestinal: nausea, vomiting, diarrhea, and constipation, particularly during dose increases, and they are usually manageable with dose timing and diet adjustments. Serious but less common risks include pancreatitis, gallbladder disease, and, in rare cases, worsening of diabetic retinopathy in patients with existing diabetic eye disease.
Semaglutide carries a boxed warning regarding thyroid C-cell tumors observed in rodent studies; the relevance to humans has not been determined, but it is why a personal or family history of medullary thyroid carcinoma or MEN2 syndrome is a contraindication we screen for at intake. Tirzepatide carries the same class warning. Neither medication is appropriate during pregnancy, and we discuss contraception planning with anyone of childbearing potential before starting.
We monitor patients every 4 to 6 weeks during titration specifically to catch side effects early, adjust the dose or timing, and confirm the medication is still the right fit. Once you reach a stable maintenance dose, follow-up moves to a less frequent, clinically appropriate cadence. If you develop severe abdominal pain, signs of a gallbladder attack, or symptoms of an allergic reaction, that is a same-day call, not a wait-and-see.
Most patients see the first meaningful movement on the scale within 4 to 8 weeks of starting a GLP-1 medication. Weight loss is typically fastest in the first 3 to 6 months, and it is normal, not a failure, for the rate to slow substantially after that. We set this expectation up front because a lot of the disappointment we see in patients coming from other programs traces back to nobody explaining the actual curve.
Before prescribing, we order HbA1c and fasting glucose to screen for prediabetes or type 2 diabetes, a comprehensive metabolic panel for kidney and liver function, a lipid panel for the cardiovascular picture, and TSH because thyroid disease drives weight changes and is frequently missed. Additional labs are ordered based on what your history suggests.
Plan for about 45 minutes, by video or in person at the Tampa (Carrollwood) office, for a history and focused exam, with the blood draw at a Quest or Labcorp near you. A decision on the treatment direction is typically made the same day once your history and exam are complete; final medication approval depends on lab results, which usually return within a few business days. If labs support it and there are no contraindications, we send the initial prescription once results are back and book your first titration follow-up at 4 to 6 weeks. If labs point somewhere else entirely, such as untreated type 2 diabetes or a metabolic issue that needs attention first, we tell you that too.
Ongoing monitoring is not a formality. During titration we are watching tolerance and any early warning signs; at maintenance we run routine checks. Because weight management sits inside family medicine here, anything the labs surface beyond weight, from an abnormal thyroid panel to early kidney changes, gets managed in the same practice rather than referred out.
Prediabetes deserves its own sentence, because the corridor's growth keeps delivering patients who've never had a baseline drawn here. Caught in that 5.7 to 6.4 window, progression to type 2 diabetes is often still preventable, and weight management is a central lever for preventing it. A GLP-1 evaluation that surfaces the number, tracks it, and treats around it is doing double duty, which is hard to replicate when the injection and the bloodwork live in different buildings.
For most patients, appetite tends to return toward baseline within weeks of stopping a GLP-1 medication, and published follow-up data shows a meaningful portion of lost weight is regained over the following year without a lifestyle and, in some cases, maintenance-medication plan in place. This is exactly why we treat weight as a chronic condition rather than a course of treatment with a fixed end date.
Before anyone stops a GLP-1 medication, whether by choice, coverage, or supply issues, we talk through a plan: lifestyle reinforcement, possible dose tapering, and what warning signs to watch for. Plateaus are a normal, well-documented part of GLP-1 treatment, typically appearing somewhere between roughly 20 and 60 weeks as the body adapts metabolically. A plateau is not a sign the medication has failed; it is a prompt to review dose, timing, and lifestyle at a follow-up visit and decide whether an adjustment makes sense. If your preferred medication or dose goes on backorder, we discuss alternatives, including a different dose, the alternate brand-name medication, or a temporary bridge plan, rather than leaving you to sort it out with the pharmacy alone.
The office visit and the medication are covered separately. We are transparent about both and we verify before we prescribe.
We work with many major commercial plans and offer self-pay options. Coverage varies by plan and service. Our team will confirm with you. Whether your plan covers the GLP-1 medication itself is a separate question that depends on your specific pharmacy benefit and the diagnosis code used. We verify your benefits and check for prior authorization before any prescription is sent, so you are not surprised at the pharmacy counter.
Coverage of the GLP-1 medication depends heavily on your plan and diagnosis: a type 2 diabetes diagnosis generally has better pharmacy coverage than a weight-management-only indication, and some plans exclude weight-loss medications entirely regardless of diagnosis. Rather than quote you a figure that may be outdated by the time you fill a prescription, our team will confirm your coverage with you, including any manufacturer assistance program you may be eligible for.
Any Wesley Chapel weight-loss provider that quotes one flat number before seeing your labs is estimating, not confirming. Our team will walk you through exactly what your benefits cover once we have verified them. Call (813) 670-3331 and we will start that verification.
Your first visit and initial workup can happen by Florida telehealth, with labs at a Quest or Labcorp near you, or in person at our Tampa (Carrollwood) office if you prefer it or need an exam, and established patients can typically continue their GLP-1 prescription and titration follow-ups by Florida telehealth, with in-person checks when an exam is needed. We will tell you upfront whether your specific case needs an in-person exam, rather than promising a fully virtual program for every situation. Telehealth for this program is available to patients physically located in Florida only.
Wesley Chapel patients are seen by Florida telehealth, or in person at our Tampa (Carrollwood) office, about 25 minutes away, Monday through Friday. Patients from nearby towns can read GLP-1 weight loss in Land O' Lakes and GLP-1 weight loss in Lutz.
Ascend Mind and Body of Tampa
3971 Moran Rd Ste 101
Tampa, FL 33618
Phone: (813) 670-3331
Hours: Monday through Friday, 9:00 AM to 5:00 PM. Get directions.
| From | Measured drive |
|---|---|
| Wesley Chapel | About 25 minutes via I-275 S |
Medical weight loss is in person only at our Tampa (Carrollwood) office; Wesley Chapel patients can have every visit by Florida telehealth. The practice covers four service lines: primary care, psychiatry, ketamine therapy, and talk therapy, which is why a Wesley Chapel weight-loss patient who also needs a physical, a medication evaluation, or care for the conditions a workup surfaces can be managed within the same organization rather than starting over elsewhere.
For broader coverage, see the medical weight loss service overview or the Wesley Chapel location page for the psychiatry and ketamine care offered there.
GLP-1 medications produce meaningful weight loss for most patients who tolerate them, but they do not permanently resolve obesity, results vary substantially from person to person, and the weight tends to come back without a lasting lifestyle plan. There is no honest way to promise you a specific number on the scale.
We are not going to tell you a medication fixes everything, or that any specific agent works the same way for every person. Clinical trials show strong average results, but "helps most people" is not the same as "guarantees a specific outcome for you." Individual response varies by starting point, other conditions, and how consistently you engage with the lifestyle side of the plan.
What we can tell you: a physician-led workup catches the things a questionnaire misses, monitoring during titration keeps you safer, and pairing medication with protein-forward nutrition and resistance training protects muscle and makes the results more durable. A GLP-1 belongs in chronic weight management only when a patient meets clinical criteria, takes it under real supervision, and hears the risks stated up front. We walk through how each medication option differs before anyone starts one. That is the standard we hold, and it is the standard worth asking any Wesley Chapel weight-loss provider to meet.
The overlap between weight and the rest of the metabolic chart is the reason this program lives in family medicine. Alongside GLP-1 evaluation we routinely manage type 2 diabetes with weight management goals, hypertension tied to weight, dyslipidemia and metabolic syndrome, prediabetes in the HbA1c 5.7 to 6.4 percent range, fatty liver disease (MASLD), and the preventive care screenings that keep cardiovascular risk in view. One chart, remember, so improvement in one column is visible in all the others.
Two commitments run through all of it. Expectations get set honestly at the start, including the fact that response varies widely and that stopping the medication without a changed lifestyle usually invites the weight back. And the program never becomes a subscription on autopilot: every refill sits downstream of an actual clinical review, which is exactly what the five-minute-video alternative is structured to avoid.
If a workup surfaces something beyond weight, like type 2 diabetes, hypertension, or high cholesterol, the same physician manages ongoing chronic disease care.
Dr. Jason Saylor, DO, a board-certified osteopathic family medicine physician and Ascend's Chief Medical Officer, holds clinical responsibility. Supervision means a physician takes the history, orders and reads the labs, makes the treatment decision, and remains the person accountable when something changes. It is not a nurse line attached to a shipping operation.
No, and a program where everyone does is not a program. Some evaluations conclude that the driver is a thyroid condition, an existing prescription, untreated sleep apnea, or a metabolic diagnosis that reorders the priorities. Those patients get treated for what they actually have.
A structured nutrition approach built around adequate protein, resistance training guidance to protect muscle while weight comes down, sleep and stress review, and management of the conditions that travel with weight. That work runs alongside any medication from the first month rather than being introduced when treatment ends.
Glycemic markers to find diabetes or prediabetes, renal and hepatic function to confirm you can safely take what is being considered, a lipid profile to frame cardiovascular risk, and thyroid function because thyroid disease is among the most commonly missed explanations for a weight trajectory. Your history can add to the list.
By history rather than by preference. One acts through a single gut-hormone pathway and the other through two, and trials of the dual-pathway agent have shown larger average loss. The choice turns on what else you are being treated for, what your panel shows, and how you tolerate the early doses.
In trials, semaglutide for weight management produced average loss of roughly 15% of body weight over 68 weeks and tirzepatide roughly 20 to 22%. Averages conceal a wide spread: some patients exceed them, some fall well short, and some do not respond. Wilding JPH et al. N Engl J Med. 2021;384(11):989-1002 (STEP 1). Jastreboff AM et al. N Engl J Med. 2022;387(3):205-216 (SURMOUNT-1).
Pregnancy or planned pregnancy, an active eating disorder, prior pancreatitis, severe gastroparesis, and any personal or family history of MEN2 syndrome or medullary thyroid carcinoma. Each is a stop rather than a caution, and none of them surfaces reliably on a self-completed form.
As a documented clinical exception. Commercially manufactured medication is the default here, and a compounded preparation is used only where a physician records an individual medical need for one. Compounded preparations are not FDA-approved, and we state that before any decision rather than afterwards.
It tracks your dose steps. Each escalation gets a checkpoint, symptoms can pull the next contact forward, and labs are repeated when the clinical picture warrants rather than on an anniversary. The schedule is set by your prescriber and changes when your case does.
Gastrointestinal effects dominate the early weeks: nausea, vomiting, diarrhea, constipation, and appetite suppression that can overshoot. Most are dose-related and improve with patient titration. The uncommon but serious risks are pancreatitis and gallbladder disease, and certain existing conditions can worsen on treatment.
The visit and the medication are two separate coverage questions. A diabetes indication is generally treated more favorably than a weight management one, which frequently requires prior authorization. We verify both before a prescription decision, and the billing team confirms your specifics rather than leaving you to discover them at a pharmacy counter.
The first evaluation can be by video, with the baseline panel drawn at a Quest or Labcorp near you, or in person at the Tampa (Carrollwood) office if you prefer it or need an exam. Everything after that can run by video for established patients anywhere in Florida, which is how most people handle titration without rearranging a workday.
No. The prescriber is licensed in Florida, and telehealth care is delivered to patients physically located in Florida. If you split time between states, tell us where you will actually be during treatment so the plan is built around it.
It cannot promise you a number, and it cannot make the result permanent on its own. Response varies substantially between people, and weight commonly returns after the medication stops unless what surrounds it genuinely changed. Anyone offering you a figure in advance is selling rather than treating.
No. The Cashford Circle office is where Ascend Mind and Body's psychiatry patients are seen in person, and the GLP-1 program is not offered in person there. Wesley Chapel patients see Dr. Jason Saylor, DO by secure video, or in person at the Tampa (Carrollwood) office, about a 25-minute drive down I-275 outside rush hour. If you are also a psychiatry patient on Cashford Circle, both kinds of care still sit within one practice.
No. Dose increases are reviewed on a video check-in, and the repeat labs can be drawn at the Quest sites on State Road 54 or Foggy Creek Road or the Labcorp on Bruce B. Downs Blvd. The drive to Carrollwood, about 25 minutes outside rush hour, is there for anyone who wants a hands-on exam or for the cases where Dr. Saylor decides an in-person look would change the decision.
Two hospital emergency departments on Bruce B. Downs Blvd are open around the clock: AdventHealth Wesley Chapel and BayCare Hospital Wesley Chapel. Go for severe upper abdominal pain, especially pain that reaches the back, vomiting you cannot stop, yellowing of the skin or eyes, or being unable to keep fluids down, and call 911 for anything life-threatening. Let our care team know afterward so the plan can be adjusted.
Quest lists two Wesley Chapel patient service centers, one on State Road 54 and one on Foggy Creek Road, and Labcorp lists one on Bruce B. Downs Blvd, all inside the Wesley Chapel census area. Any of them can draw the baseline panel Dr. Saylor orders before prescribing, covering HbA1c and glucose, kidney and liver function, lipids and thyroid. Repeat labs later in treatment go to the same places.
It can be by video. Dr. Jason Saylor, DO does first visits over secure video for Florida residents, and you will be told before booking if anything about your case calls for an exam in the room. If you would simply prefer to start face to face, that appointment is at the Tampa (Carrollwood) office, about 25 minutes away. The Cashford Circle office is for psychiatry, and GLP-1 visits are not offered there. Follow-ups run by video.
Under FDA labeling for weight management, generally yes if you are an adult with a BMI of 30 or more, or 27 or more with a condition tied to weight such as type 2 diabetes, high blood pressure or sleep apnea. Qualifying on BMI is not the whole answer, though. Dr. Saylor also screens for thyroid cancer history, MEN 2, pancreatitis, gastroparesis, eating disorders and pregnancy, and reads your labs before saying yes.
Yes. Send or bring the product name, every dose and date you have taken, any side effects and any labs the med spa ran. Dr. Saylor orders a fresh panel at a Wesley Chapel Quest or Labcorp to set the baseline that should have been drawn at the start, then carries the rest of your course forward on a monitored schedule instead of an auto-refill.
Last updated 2026-07-06.
Common side effects include nausea, vomiting, diarrhea, and constipation, particularly during dose titration. Serious risks include pancreatitis and gallbladder disease. Weight-loss results vary substantially and are never promised in advance. This page is educational and does not replace an individualized clinical evaluation.
Book a video visit online, or send a request and a care coordinator will call you back. Insurance questions go to our care team, who confirm your coverage with you before your first visit.
Read next
Dr. Jason Saylor, DO sees Wesley Chapel residents by secure Florida telehealth from our Tampa (Carrollwood) office, usually within the week. If you would rather be seen in person, our Tampa (Carrollwood) office is about 25 minutes from Wesley Chapel. Our Wesley Chapel office is home to psychiatry, ADHD care and ketamine therapy; GLP-1 weight loss for Wesley Chapel residents is by secure video. Telehealth visits are for Florida residents. We work with many major commercial plans and offer self-pay options. Coverage varies by plan and service. Our team will confirm with you.
Where you are seen
Our Wesley Chapel office is home to psychiatry, ADHD care and ketamine therapy; GLP-1 weight loss for Wesley Chapel residents is by secure video. Dr. Jason Saylor, DO sees Wesley Chapel residents by secure Florida telehealth from our Tampa (Carrollwood) office. Telehealth visits are for Florida residents.
If you would rather be seen in person, our Tampa (Carrollwood) office at 3971 Moran Rd Ste 101, Tampa, FL 33618 is about 25 minutes from Wesley Chapel.